Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Letters|February 3, 2024
Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progressionLinxi Zhu, Neng Tang, Hexing Hang, et al.
Life Sciences|April 15, 2023
Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiotaYinhua Ni, Yi Zhang, Liujie Zheng, et al.
Frontiers in Oncology|November 17, 2022
Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancerJuan Du, Linxi Zhu, Huizi Sha, et al.
Genomics, Proteomics & Bioinformatics|July 5, 2026
A Cattle BodyMap of Transcriptome across 52 Tissues and 3 Developmental Stages Reveals New Genetic Insights into Beef Production TraitsWentao Cai, Yapeng Zhang, Lei Xu, et al.
Annals of Medicine|July 31, 2025
The impact of preoperative biliary drainage on bile colonization of patients undergoing pancreaticoduodenectomyYifei Yang, Yichen Duan, Chengxiang Su, et al.
Frontiers in Oncology|June 23, 2022
Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic CancerChangchang Lu, Yahui Zhu, Hao Cheng, et al.
Frontiers in Oncology|September 5, 2022
Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancerChangchang Lu, Yahui Zhu, Weiwei Kong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 20, 2025
SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic CancerHexing Hang, Mengyu Yu, Linxi Zhu, et al.
Pageof 3